Clinical Trial Update: Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis [NA]

View source ↗

Summary

A completed study evaluated whether subcutaneous insulin glargine reduces the time to closure of the anion gap in patients with diabetic ketoacidosis presenting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Ketoacidosis

Drugs mentioned

• Insulin Glargine (Lantus) (insulin glargine)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Diabetic Ketoacidosis | NA | Status: COMPLETED | Results posted: 2017-05-16